AR021749A1 - Uso de derivados de tiazolidinediona para el tratamiento o prevencion de cataratas. - Google Patents

Uso de derivados de tiazolidinediona para el tratamiento o prevencion de cataratas.

Info

Publication number
AR021749A1
AR021749A1 ARP990103895A ARP990103895A AR021749A1 AR 021749 A1 AR021749 A1 AR 021749A1 AR P990103895 A ARP990103895 A AR P990103895A AR P990103895 A ARP990103895 A AR P990103895A AR 021749 A1 AR021749 A1 AR 021749A1
Authority
AR
Argentina
Prior art keywords
derivatives
tiazolidinediona
catarats
prevention
treatment
Prior art date
Application number
ARP990103895A
Other languages
English (en)
Spanish (es)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of AR021749A1 publication Critical patent/AR021749A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ARP990103895A 1998-08-06 1999-08-05 Uso de derivados de tiazolidinediona para el tratamiento o prevencion de cataratas. AR021749A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9551898P 1998-08-06 1998-08-06

Publications (1)

Publication Number Publication Date
AR021749A1 true AR021749A1 (es) 2002-08-07

Family

ID=22252372

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103895A AR021749A1 (es) 1998-08-06 1999-08-05 Uso de derivados de tiazolidinediona para el tratamiento o prevencion de cataratas.

Country Status (5)

Country Link
AR (1) AR021749A1 (fr)
CO (1) CO5050324A1 (fr)
PE (1) PE20000946A1 (fr)
UY (1) UY25643A1 (fr)
WO (1) WO2000007582A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111511402A (zh) * 2017-12-28 2020-08-07 国立大学法人福井大学 白内障的预防剂及/或治疗剂、用于预防及/或治疗白内障的医药组合物、ppar活化剂的用于制造它们的用途、以及滴眼剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
JPS62234085A (ja) * 1985-12-18 1987-10-14 Sankyo Co Ltd チアゾリジン誘導体を有効成分とする糖尿病性合併症治療剤
US4873255A (en) * 1987-02-04 1989-10-10 Sankyo Company Limited Thiazolidinone derivatives, their preparation and their use
KR20000036035A (ko) * 1996-09-12 2000-06-26 가와무라 요시부미 트로글리타존을 함유하는 글루타티온 환원효소 활성증강제
IL123887A0 (en) * 1997-04-02 1998-10-30 Sankyo Co Dithiolan derivatives their use and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
CO5050324A1 (es) 2001-06-27
UY25643A1 (es) 1999-11-17
WO2000007582A3 (fr) 2000-06-22
WO2000007582A2 (fr) 2000-02-17
PE20000946A1 (es) 2000-10-18

Similar Documents

Publication Publication Date Title
NO992492L (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
ECSP045429A (es) Combinacion de compuestos organicos
BRPI0412404A (pt) uso de rapamicina e de derivado da rapamicina para o tratamento da perda óssea
PT1073658E (pt) Inibidores de ogmp pdes de pirazolopirimidinona para o tratamento da disfuncao sexual
EE200300440A (et) Epotilooni analoogide ja kemoterapeutikumide kombinatsioon proliferatiivsete haiguste raviks
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
ES2196547T3 (es) Tratamiento de infartos por inhibicion de nf-kappab.
HN1998000174A (es) Combinacion eficaz para el tratamiento de la impotencia
ID30062A (id) Alanog-analog benzopiran tersubstitusi untuk pengobatan radang
ES2186811T3 (es) Derivados de feniltiazol con propiedades anti-virus herpes.
DE60229922D1 (de) Kombinationen, ein antidiarrhoikum und epothilon oder ein epothilonderivat enthaltend
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
ES2184127T3 (es) Derivados de sulfamato anticonvulsivos utiles para el tratamiento de la obesidad.
ES2164842T3 (es) Procedimiento para la preparacion de composiciones de microcapsulas.
PA8484301A1 (es) Formulaciones farmaceuticas de liberacion controlada
UY28314A1 (es) Preparacion y uso de derivados de alquilarilo para el tratamiento de la obesidad
GT200300053A (es) Compuestos que modulan la actividad de ppar
BRPI0413848A (pt) composto, processo para preparar o composto, composição terapêutica para prevenir inflamação e apoptose, método para prevenir inflamação e apoptose, e, uso de composto inibidor de caspase, ou de seu sal, ou de seu estereoisÈmero
PT1411926E (pt) Inibidores de integrina para o tratamento de doencas oftalmicas
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
DK0934065T3 (da) Hidtil ukendte cruptophycinderivater som antieoplastiske midler
BR0307894A (pt) Heterocìclos tricìclicos fundidos úteis para o tratamento de distúrbios hiperproliferativos
MX9703944A (es) Metodo para usar derivados de triaril-etileno en el tratamiento y prevencion de osteoporosis.
AR039664A1 (es) Composicion farmaceutica que comprende un inhibidor de lipasa y glucomanan
ES2169022T3 (es) Utilizacion de derivados de (piridil-metil-sulfinil)-1-h-bencimidazol para el tratamiento de enfermedades provocadas por helicobacter.